Immediate Impact
1 from Science/Nature 68 standout
Citing Papers
NF-κB in biology and targeted therapy: new insights and translational implications
2024 Standout
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Works of Umberto Conte being referenced
Efficacy and safety of elranatamab in patients with relapsed/refractory multiple myeloma (RRMM) and prior B-cell maturation antigen (BCMA)-directed therapies: A pooled analysis from MagnetisMM studies.
2023
Elranatamab, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, for patients (pts) with relapsed/refractory multiple myeloma (RRMM): Extended follow up and biweekly administration from the MagnetisMM-3 study.
2023
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Umberto Conte | 59 | 101 | 142 | 150 | 25 | 333 | |
| Nicola Susca | 24 | 106 | 77 | 78 | 20 | 294 | |
| Shun Iida | 53 | 115 | 49 | 46 | 32 | 326 | |
| L Lemaître | 20 | 59 | 70 | 134 | 21 | 337 | |
| Mónica Enguita‐Germán | 30 | 81 | 100 | 148 | 19 | 330 | |
| Abdelmonem Elhosseiny | 30 | 55 | 105 | 42 | 19 | 329 | |
| Haoran Zhang | 27 | 82 | 82 | 56 | 37 | 264 | |
| Young Bae Choi | 90 | 52 | 63 | 40 | 35 | 294 | |
| Maxime Chénard-Poirier | 34 | 141 | 173 | 77 | 29 | 340 | |
| Naohiro Uchida | 34 | 51 | 173 | 121 | 32 | 357 | |
| Sara R. Rashkin | 33 | 129 | 85 | 42 | 15 | 361 |
All Works
Loading papers...